FI68398C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat Download PDF

Info

Publication number
FI68398C
FI68398C FI792699A FI792699A FI68398C FI 68398 C FI68398 C FI 68398C FI 792699 A FI792699 A FI 792699A FI 792699 A FI792699 A FI 792699A FI 68398 C FI68398 C FI 68398C
Authority
FI
Finland
Prior art keywords
group
carbostyril
formula
colorless
reaction
Prior art date
Application number
FI792699A
Other languages
English (en)
Finnish (fi)
Other versions
FI68398B (fi
FI792699A7 (fi
Inventor
Takao Nishi
Kazuyuki Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14470137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI68398(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of FI792699A7 publication Critical patent/FI792699A7/fi
Publication of FI68398B publication Critical patent/FI68398B/fi
Application granted granted Critical
Publication of FI68398C publication Critical patent/FI68398C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI792699A 1978-09-01 1979-08-30 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat FI68398C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10786978A JPS5535019A (en) 1978-09-01 1978-09-01 Carbostyryl derivative
JP10786978 1978-09-01

Publications (3)

Publication Number Publication Date
FI792699A7 FI792699A7 (fi) 1980-03-02
FI68398B FI68398B (fi) 1985-05-31
FI68398C true FI68398C (fi) 1985-09-10

Family

ID=14470137

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792699A FI68398C (fi) 1978-09-01 1979-08-30 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat

Country Status (23)

Country Link
US (1) US4277479A (enEXAMPLES)
JP (1) JPS5535019A (enEXAMPLES)
AR (1) AR229342A1 (enEXAMPLES)
AT (1) AT364363B (enEXAMPLES)
AU (1) AU538410B2 (enEXAMPLES)
BE (1) BE878548A (enEXAMPLES)
CA (1) CA1139761A (enEXAMPLES)
CH (1) CH641799A5 (enEXAMPLES)
DE (1) DE2934747A1 (enEXAMPLES)
DK (1) DK158788C (enEXAMPLES)
ES (1) ES483792A1 (enEXAMPLES)
FI (1) FI68398C (enEXAMPLES)
FR (1) FR2434809A1 (enEXAMPLES)
GB (1) GB2033893B (enEXAMPLES)
IT (1) IT1119929B (enEXAMPLES)
MX (1) MX6749E (enEXAMPLES)
NL (1) NL183888C (enEXAMPLES)
NO (1) NO153177C (enEXAMPLES)
PH (1) PH18452A (enEXAMPLES)
PT (1) PT70136A (enEXAMPLES)
SE (1) SE432252B (enEXAMPLES)
SU (1) SU1064868A3 (enEXAMPLES)
ZA (1) ZA794627B (enEXAMPLES)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57156469A (en) * 1981-03-19 1982-09-27 Otsuka Pharmaceut Co Ltd Preparation of tetrazole derivative
JPS57183761A (en) * 1981-04-30 1982-11-12 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5859980A (ja) * 1981-10-05 1983-04-09 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5877880A (ja) * 1981-11-05 1983-05-11 Otsuka Pharmaceut Co Ltd テトラゾ−ル誘導体
DE3225169A1 (de) * 1982-07-06 1984-01-12 Basf Ag, 6700 Ludwigshafen Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen
US4803162A (en) * 1984-05-15 1989-02-07 Fluorodiagnostic Limited Partners Composition, article and process for detecting a microorganism
GR851296B (enEXAMPLES) * 1984-05-29 1985-11-25 Pfizer
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
JPH0681727B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 血小板粘着抑制剤
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
JPH0681752B2 (ja) * 1986-04-02 1994-10-19 大塚製薬株式会社 カルボスチリル誘導体
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
JPH07100648B1 (enEXAMPLES) * 1990-01-08 1995-11-01
TW201305B (enEXAMPLES) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
AU653060B2 (en) * 1991-08-23 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelet agglutination inhibitor
JPH0776521A (ja) * 1993-09-07 1995-03-20 Otsuka Pharmaceut Co Ltd 気道炎症抑制剤
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
JP4060523B2 (ja) * 1999-11-24 2008-03-12 大塚製薬株式会社 カルボスチリル誘導体の製造法
US20030045547A1 (en) 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
US6515128B2 (en) 2000-03-20 2003-02-04 Teva Pharmaceutical Industries Ltd. Processes for preparing cilostazol
US6825214B2 (en) * 2000-08-14 2004-11-30 Teva Pharmaceutical Industries, Ltd. Substantially pure cilostazol and processes for making same
WO2001070697A1 (en) 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
KR20030024865A (ko) * 2000-08-14 2003-03-26 테바 파마슈티컬 인더스트리즈 리미티드 실로스타졸을 제조하는 방법
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US20050101631A1 (en) * 2002-08-01 2005-05-12 Otsuka Pharmaceuticals Company Process for producing carbostyril derivatives
US7399864B2 (en) * 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
JP2003063965A (ja) * 2001-06-13 2003-03-05 Otsuka Pharmaceut Factory Inc 注射用シロスタゾール水性製剤
US6596871B2 (en) * 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) * 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002121A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) * 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002529A2 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6657061B2 (en) * 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) * 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2004024716A1 (ja) * 2002-09-10 2004-03-25 Otsuka Pharmaceutical Co., Ltd. シロスタゾールの製造法
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
TWI323660B (en) 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
ITMI20031670A1 (it) * 2003-08-26 2005-02-27 Dinamite Dipharma S P A In Forma A Bbreviata Diph Processo per la preparazione di cilostazolo e di suoi intermedi.
IL167483A (en) * 2004-03-16 2011-04-28 Chemagis Ltd Process for obtaining highly pure cilostazol
US20050255155A1 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Modified release cilostazol compositions
US20080206348A1 (en) * 2004-09-17 2008-08-28 Deepak Murpani Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers
CN100462360C (zh) * 2005-08-15 2009-02-18 上海立科药物化学有限公司 N-环己基-5-(4-氯丁基)-1h-四氮唑的合成方法
PL1942895T3 (pl) * 2005-09-15 2012-07-31 Otsuka Pharma Co Ltd Lek złożony zawierający probukol i pochodną tetrazoliloalkoksydihydrokarbostyrylu o działaniu hamującym nadtlenek
US20070105898A1 (en) * 2005-11-09 2007-05-10 Apotex Pharmachem Inc. Process for the production of cilostazol
AR065588A1 (es) 2007-03-09 2009-06-17 Otsuka Pharma Co Ltd Un medicamento para tratar enfermedad pulmonar obstructiva cronica
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
EP2527336A1 (en) 2007-04-25 2012-11-28 Concert Pharmaceuticals Inc. Deuterated analogues of cilostazol
US8349817B2 (en) 2007-04-25 2013-01-08 Concert Pharmaceuticals, Inc. Analogues of cilostazol
US20100298375A1 (en) 2007-05-22 2010-11-25 Heii Arai medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
EP2194048A1 (en) * 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN119350296A (zh) * 2023-07-24 2025-01-24 南京宁丹新药技术有限公司 一类取代的喹啉酮类衍生物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470084A (en) * 1945-09-25 1949-05-17 Bilhuber Inc E Substituted alpha-halogen alkyl tetrazoles and process for obtaining the same
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5310986B2 (enEXAMPLES) * 1974-02-05 1978-04-18
JPS5310989B2 (enEXAMPLES) * 1974-04-25 1978-04-18
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
JPS52116482A (en) * 1976-03-24 1977-09-29 Otsuka Pharmaceut Co Ltd Carbostyril derivatives and its preparation
JPS5430183A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative

Also Published As

Publication number Publication date
FR2434809A1 (fr) 1980-03-28
ZA794627B (en) 1980-08-27
BE878548A (fr) 1979-12-17
MX6749E (es) 1986-06-25
NO153177B (no) 1985-10-21
GB2033893B (en) 1982-12-01
NO153177C (no) 1986-01-29
PT70136A (en) 1979-09-01
DE2934747C2 (enEXAMPLES) 1988-01-28
FR2434809B1 (enEXAMPLES) 1982-09-17
NL183888C (nl) 1989-02-16
NL7906523A (nl) 1980-03-04
DE2934747A1 (de) 1980-03-13
ATA584579A (de) 1981-03-15
GB2033893A (en) 1980-05-29
AT364363B (de) 1981-10-12
AR229342A1 (es) 1983-07-29
DK363179A (da) 1980-03-02
AU5039779A (en) 1980-03-06
DK158788C (da) 1990-12-10
SE7907236L (sv) 1980-03-02
FI68398B (fi) 1985-05-31
JPS5535019A (en) 1980-03-11
CA1139761A (en) 1983-01-18
US4277479A (en) 1981-07-07
CH641799A5 (de) 1984-03-15
SE432252B (sv) 1984-03-26
PH18452A (en) 1985-07-18
JPS6155514B2 (enEXAMPLES) 1986-11-28
IT7968748A0 (it) 1979-08-31
DK158788B (da) 1990-07-16
NO792829L (no) 1980-03-04
FI792699A7 (fi) 1980-03-02
IT1119929B (it) 1986-03-19
SU1064868A3 (ru) 1983-12-30
ES483792A1 (es) 1980-09-01
AU538410B2 (en) 1984-08-16

Similar Documents

Publication Publication Date Title
FI68398C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat
EP0264586B1 (en) Hydantoin derivatives for treating complications of diabetes
US4564619A (en) Carbostyril derivative
EP0357788B1 (en) Pyridazinone derivatives
JPS6089474A (ja) モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤
IE62680B1 (en) Leukotriene b4 antagonists
EP0194161B1 (en) Cyclopenta[d]pyrimidine derivatives, their preparation and use
US4266060A (en) Dipyrido [4,3-b] [3,4-f] indoles and process for obtaining them
US5696143A (en) Benz G! indazolyl derivatives for the treatment of inflammation
HK1005450B (en) Cyclopenta [d] pyrimidine derivatives, their preparation and use
FI93013C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi
PL119501B1 (en) Process for manufacturing novel,condensed pyrimidine derivatives pirimidina
EP0145010B1 (en) Carbostyril derivatives
JPS6026373B2 (ja) 抗腸瘍剤
EP0618206A1 (en) Pharmaceutical compounds
CA1140928A (en) Aldose reductase inhibiting quinolylhydantions
JP2003503503A (ja) 新規のキサントン化合物、その製造および医薬としての使用
EP0481243A1 (en) Tricyclic heterocyclic compounds, their production and use
US4372956A (en) 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them
NO169388B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-amino-1,2-ditiol-3-onderivater
JPH01110680A (ja) １，２，３，４−テトラヒドロイソキノリン抗不整脈薬
US4302463A (en) 1-Azaxanthone-3-carboxylic acids and their production
KR790001695B1 (ko) 벤즈사이클로아미드 유도체의 제조법
GB1598127A (en) Benzoxazine carboxamides having lipogenesis-inhibiting properties
KR830000149B1 (ko) 신규 테트라졸릴 알콕시카르보스티릴 유도체의 제조방법

Legal Events

Date Code Title Description
MA Patent expired

Owner name: OTSUKA PHARMACEUTICAL CO., LTD.